CoumarinCoumarin (ˈkuːmərɪn) or 2H-chromen-2-one is an aromatic organic chemical compound with formula . Its molecule can be described as a benzene molecule with two adjacent hydrogen atoms replaced by an unsaturated lactone ring , forming a second six-membered heterocycle that shares two carbons with the benzene ring. It belongs to the benzopyrone chemical class and considered as a lactone. Coumarin is a colorless crystalline solid with a sweet odor resembling the scent of vanilla and a bitter taste.
White dwarfA white dwarf is a stellar core remnant composed mostly of electron-degenerate matter. A white dwarf is very dense: its mass is comparable to the Sun's, while its volume is comparable to the Earth's. A white dwarf's low luminosity comes from the emission of residual thermal energy; no fusion takes place in a white dwarf. The nearest known white dwarf is Sirius B, at 8.6 light years, the smaller component of the Sirius binary star. There are currently thought to be eight white dwarfs among the hundred star systems nearest the Sun.
VegaVega is the brightest star in the northern constellation of Lyra. It has the Bayer designation α Lyrae, which is Latinised to Alpha Lyrae and abbreviated Alpha Lyr or α Lyr. This star is relatively close at only from the Sun, and one of the most luminous stars in the Sun's neighborhood. It is the fifth-brightest star in the night sky, and the second-brightest star in the northern celestial hemisphere, after Arcturus. Vega has been extensively studied by astronomers, leading it to be termed "arguably the next most important star in the sky after the Sun".
PhenprocoumonPhenprocoumon (marketed under the brand names Marcoumar, Marcumar and Falithrom) is a long-acting blood thinner drug to be taken by mouth, and a derivative of coumarin. It acts as a vitamin K antagonist and inhibits blood clotting (coagulation) by blocking synthesis of coagulation factors II, VII, IX and X. It is used for the prophylaxis and treatment of thromboembolic disorders such as heart attacks and pulmonary (lung) embolism. The most common adverse effect is bleeding.
